HEMOPHILIA GENE THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Hemophilia Type
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Pipeline Analysis
• Primary Research Respondents View About Market
• Mergers, Acquisitions, and Collaborations
• Regulatory Scenario
• PEST Analysis
• Epidemiological Data

4. Global Hemophilia Gene Therapy Market, By Hemophilia Type, 2026-2033, (USD Mn)

• Introduction
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Hemophilia A
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Hemophilia B
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends

5. Global Hemophilia Gene Therapy Market, By Region, 2026-2033, (USD Mn)

• Introduction
• Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
• Market Size and Forecast, By Country, 2026-2033, (USD Mn)
• U.S.
• Canada
• Latin America
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
• Market Size and Forecast, By Country, 2026-2033, (USD Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
• Market Size and Forecast, By Country, 2026-2033, (USD Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
• Market Size and Forecast, By Country, 2026-2033, (USD Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
• Market Size and Forecast, By Country, 2026-2033, (USD Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
• Market Size and Forecast, By Country, 2026-2033, (USD Mn)
• North Africa
• Central Africa
• South Africa

6. Competitive Landscape

• Market Share Analysis
• Company Profiles
• BioMarin Pharmaceuticals, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Spark Therapeutics
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Pfizer, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• UniQure NV
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Ultragenyx Pharmaceutical
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Shire PLC
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Sangamo Therapeutics, Inc
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Freeline Therapeutics
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Analyst Views

7. Section

• References
• Research Methodology
• About Us and Sales Contact